Subtyping the irritable bowel syndrome by predominant bowel habit:: Rome II versus Rome III

被引:62
作者
Ersryd, A. [1 ]
Posserud, I. [1 ]
Abrahamsson, H. [1 ]
Simren, M. [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Internal Med, Sect Gastroenterol & hepatol, S-41345 Gothenburg, Sweden
关键词
D O I
10.1111/j.1365-2036.2007.03422.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The agreement between subtyping irritable bowel syndrome (IBS) patients based on Rome II criteria versus Rome III criteria is unknown. Aim To compare IBS subtyping based on Rome II versus III criteria. Methods The Rome II Modular Questionnaire and the Bristol Stool Form Scale (one-week diary cards) were completed by 249 IBS patients. Based on the Rome II criteria, patients were defined as having diarrhoea- or constipation-predominant IBS, or alternating IBS. Based on the Rome III criteria, patients were divided into IBS with constipation, IBS with diarrhoea, mixed IBS or unsubtyped IBS. Agreement between Rome II and Rome III was assessed with kappa statistics. Results Based on Rome II there were 92 diarrhoea-predominant IBS, 45 constipation-predominant IBS and 112 alternating IBS, and based on Rome III 97 IBS with diarrhoea, 77 IBS with constipation, 16 mixed IBS and 59 unsubtyped IBS. The agreement between Rome II and Rome III subgroups was 46% (kappa = 0.19). Changes from the constipation to the diarrhoea subgroups and vice versa were uncommon (8% of patients). The majority of changes occurred from/to the alternating IBS, mixed IBS and unsubtyped IBS subgroups. Conclusion There is poor agreement between subtyping of IBS patients based on Rome II versus Rome III criteria.
引用
收藏
页码:953 / 961
页数:9
相关论文
共 37 条
[1]   IRRITABLE-BOWEL-SYNDROME AND DYSPEPSIA IN THE GENERAL-POPULATION - OVERLAP AND LACK OF STABILITY OVER TIME [J].
AGREUS, L ;
SVARDSUDD, K ;
NYREN, O ;
TIBBLIN, G .
GASTROENTEROLOGY, 1995, 109 (03) :671-680
[2]  
Altman DG., 1990, PRACTICAL STAT MED R
[3]   Rectal distention testing in patients with irritable bowel syndrome:: Sensitivity, specificity, and predictive values of pain sensory thresholds [J].
Bouin, M ;
Plourde, V ;
Boivin, M ;
Riberdy, M ;
Lupien, F ;
Laganière, M ;
Verrier, P ;
Poitras, P .
GASTROENTEROLOGY, 2002, 122 (07) :1771-1777
[4]   A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome [J].
Camilleri, M ;
Chey, WY ;
Mayer, EA ;
Northcutt, AR ;
Heath, A ;
Dukes, GE ;
McSorley, D ;
Mangel, AM .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (14) :1733-1740
[5]   Review article: tegaserod - the global experience [J].
Chey, WD .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 :15-19
[6]   UNITED-STATES HOUSEHOLDER SURVEY OF FUNCTIONAL GASTROINTESTINAL DISORDERS - PREVALENCE, SOCIODEMOGRAPHY, AND HEALTH IMPACT [J].
DROSSMAN, DA ;
LI, ZM ;
ANDRUZZI, E ;
TEMPLE, RD ;
TALLEY, NJ ;
THOMPSON, WG ;
WHITEHEAD, WE ;
JANSSENS, J ;
FUNCHJENSEN, P ;
CORAZZIARI, E ;
RICHTER, JE ;
KOCH, GG .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (09) :1569-1580
[7]   A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator [J].
Drossman, DA ;
Morris, CB ;
Hu, YM ;
Toner, BB ;
Diamant, N ;
Leserman, J ;
Shetzline, M ;
Dalton, C ;
Bangdiwala, SI .
GASTROENTEROLOGY, 2005, 128 (03) :580-589
[8]  
Drossman DA, 2000, ROME 2 FUNCTIONAL GA, P669
[9]   Change over time of bowel habit in irritable bowel syndrome:: a prospective, observational, 1-year follow-up study (RITMO study) [J].
Garrigues, V. ;
Mearin, F. ;
Badia, X. ;
Balboa, A. ;
Benavent, J. ;
Caballero, A. ;
Dominguez, E. ;
Diaz-Rubio, M. ;
Roset, M. ;
Figueras, M. ;
Cucala, M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (03) :323-332
[10]   SELECTIVE AFFECTIVE BIASING IN RECOGNITION MEMORY IN THE IRRITABLE-BOWEL-SYNDROME [J].
GOMBORONE, JE ;
DEWSNAP, PA ;
LIBBY, GW ;
FARTHING, MJG .
GUT, 1993, 34 (09) :1230-1233